3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Suspended
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Prostatic Neoplasms
2
Neoplasms
2
Leukemia
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Tissue Adhesions
1
Radiation Injuries
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Pain, Intractable
1
Ovarian Neoplasms
1
Ovarian Cysts
1
Neurotoxicity Syndromes
1
Neoplasm Metastasis
1
NSCLC
1
Multiple Myeloma
1
Mucositis
1
Malnutrition
1
Malignant Female Reproductive System Neoplasm
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Glioblastoma
1
Fatigue
1
Fasting Mimicking Diet
1
Eyelid Squamous Cell Carcinoma
1
Endometriosis
1
Interventions
Heparin
1
Enoxaparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Suspended
×
Malignant Female Reproductive System Neoplasm
×
Clear all
NCT01356329
2016-05-13
Lovenox
National Guard Health Affairs
Phase 3
Suspended
150 enrolled